St. Jude Medical (NYSE: STJ) reported earnings on April 18. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended March 31 (Q1), St. Jude Medical beat slightly on revenue and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue improved slightly and GAAP earnings per share contracted.

Margins contracted across the board.

Revenue details
St. Jude Medical notched revenue of $1.40 billion. The 22 analysts polled by S&P Capital IQ wanted to see a top line of $1.37 billion on the same basis. GAAP reported sales were 1.4% higher than the prior-year quarter's $1.38 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Non-GAAP EPS came in at $0.86. The 26 earnings estimates compiled by S&P Capital IQ predicted $0.83 per share on the same basis. GAAP EPS of $0.67 for Q1 were 5.6% lower than the prior-year quarter's $0.71 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 74.3%, 30 basis points worse than the prior-year quarter. Operating margin was 21.6%, 470 basis points worse than the prior-year quarter. Net margin was 15.2%, 180 basis points worse than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $1.45 billion. On the bottom line, the average EPS estimate is $0.88.

Next year's average estimate for revenue is $5.72 billion. The average EPS estimate is $3.47.

Investor sentiment
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on St. Jude Medical is outperform, with an average price target of $46.86.

Can your portfolio provide you with enough income to last through retirement? You'll need more than St. Jude Medical. Learn how to maximize your investment income in our free report: "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.